Cargando…
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination
As the coronavirus disease 2019 (COVID-19) pandemic is ongoing and new variants of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) are emerging, there is an urgent need for COVID-19 vaccines to control disease outbreaks by herd immunity. Surveillance of rare safety issues related t...
Autores principales: | Hakroush, Samy, Tampe, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514980/ https://www.ncbi.nlm.nih.gov/pubmed/34659268 http://dx.doi.org/10.3389/fimmu.2021.762006 |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Antineutrophil cytoplasmic autoantibody and pauci-immune crescentic glomerulonephritis: case report
Publicado: (2022) -
Pauci-Immune Crescentic Glomerulonephritis: An ANCA-Associated Vasculitis
por: Syed, Rafeel, et al.
Publicado: (2015) -
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2021) -
A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination
por: Kim, Sujeong, et al.
Publicado: (2022) -
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021)